Compare GDTC & JZXN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GDTC | JZXN |
|---|---|---|
| Founded | 2018 | 2019 |
| Country | Singapore | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Retail-Auto Dealers and Gas Stations |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.5M | 16.2M |
| IPO Year | 2023 | 2021 |
| Metric | GDTC | JZXN |
|---|---|---|
| Price | $1.02 | $1.12 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 173.3K | ★ 550.3K |
| Earning Date | 04-24-2026 | 03-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $573,193.00 | $97,465.00 |
| Revenue This Year | $5.37 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 63.03 | N/A |
| 52 Week Low | $0.73 | $1.09 |
| 52 Week High | $3.68 | $312.80 |
| Indicator | GDTC | JZXN |
|---|---|---|
| Relative Strength Index (RSI) | 45.90 | 34.44 |
| Support Level | $0.80 | $1.17 |
| Resistance Level | $0.90 | $1.78 |
| Average True Range (ATR) | 0.11 | 0.15 |
| MACD | 0.02 | -0.10 |
| Stochastic Oscillator | 73.89 | 8.70 |
CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The company's segment include: the business of innate immune cell-based immunotherapy, pluripotent stem cell-based therapy and undertaking the research and development of immune cell and stem cell-based therapy; and the business of processing and banking of cells including cord blood stem cells, research and development on cord blood derived cell-based therapy. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.
Jiuzi Holdings Inc operates as a franchise under the brand name Jiuzi. It sells new energy vehicles in third-fourth tier cities in China. The firm also sells plug-in electric vehicles on demand from vehicle buyers. Its operating segments are propretaey product; and resale of sourced Equipment and accessories from third party products. The company generates a majority of its revenue from the propretaey product segment. Geographically, the firm operates in China.